Eli Lilly publishes revenue of $8 billion for the 4th quarter of 2021, up 8% compared to the 4th quarter of 2020.
The laboratory publishes quarterly adjusted net profit up 8% , at $2.26 billion, representing adjusted EPS of $2.49.
Over the whole of the 2021 financial year, Eli Lilly recorded revenue of $28.3 billion, up 15% compared to 2020.
Adjusted annual net profit thus increased by 20%, to $7.43 billion. $ in 2021, i.e. an EPS of $8.16.
For 2022, Eli Lilly is targeting revenue of between $27.8 and $28.3 billion and adjusted EPS of between $8.5 and $8.65.
Post a Comment